- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/40 - Hydrolases (3.) acting on glycosyl compounds (3.2) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase
Patent holdings for IPC class C12N 9/40
Total number of patents in this class: 272
10-year publication summary
|
19
|
18
|
24
|
25
|
22
|
29
|
20
|
20
|
12
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Translate bio, Inc. | 413 |
27 |
| Amicus Therapeutics, Inc. | 354 |
20 |
| Genzyme Corporation | 1369 |
12 |
| Novozymes A/S | 3382 |
10 |
| Protalix Ltd. | 51 |
10 |
| Crosswalk Therapeutics, Inc. | 14 |
10 |
| Wyeth Holdings LLC | 51 |
7 |
| JCR Pharmaceuticals Co., Ltd. | 230 |
7 |
| Takeda Pharmaceutical Company Limited | 2715 |
6 |
| Research Foundation of the City University of New York | 446 |
6 |
| Vib VZW | 902 |
6 |
| Sangamo Therapeutics, Inc. | 383 |
6 |
| Hanmi Pharm. Co., Ltd. | 601 |
5 |
| Modernatx, Inc. | 1291 |
5 |
| University of Maryland, College Park | 1085 |
5 |
| Battelle Energy Alliance, LLC | 585 |
4 |
| Indiana University Research and Technology Corporation | 781 |
4 |
| University Health Network | 1061 |
4 |
| Sigilon Therapeutics, Inc. | 112 |
4 |
| DSM IP Assets B.V. | 5376 |
3 |
| Other owners | 111 |